873943-00-1Relevant articles and documents
Identification and evaluation of 4-anilinoquin(az)olines as potent inhibitors of both dengue virus (DENV) and Venezuelan equine encephalitis virus (VEEV)
Asquith, Christopher R. M.,Einav, Shirit,Huang, Pei-Tzu,Saul, Sirle
, (2021/11/01)
There is an urgent need for novel strategies for the treatment of emerging arthropod-borne viral infections, including those caused by dengue virus (DENV) and Venezuelan equine encephalitis virus (VEEV). We prepared and screened focused libraries of 4-anilinoquinolines and 4-anilinoquinazolines for antiviral activity and identified three potent compounds. N-(2,5-dimethoxyphenyl)-6-(trifluoromethyl)quinolin-4-amine (10) inhibited DENV infection with an EC50 = 0.25 μM, N-(3,4-dichlorophenyl)-6-(trifluoromethyl)quinolin-4-amine (27) inhibited VEEV with an EC50 = 0.50 μM, while N-(3-ethynyl-4-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine (54) inhibited VEEV with an EC50 = 0.60 μM. These series of compounds demonstrated nearly no toxicity with CC50 values greater than 10 μM in all cases. These promising results provide a future prospective to develop a clinical compound against these emerging viral threats.
METHODS AND COMPOSITIONS FOR THE TREATMENT OF BODY COMPOSITION DISORDERS
-
Page/Page column 43, (2008/12/07)
This invention relates to methods of treating, managing and preventing body composition disorders, and to compounds and pharmaceutical compositions useful in such methods.